CAVA CAVA GROUP, INC. Insider Trading

Kelly Costanza sells 12,490 CAVA shares at $90.00 ($1.1M); stock now $88.05. Pattern shows 4 of 4 prior sales at CAVA were well-timed (90d declines).

Chief People Officer Kelly Costanza sold 12.5K shares (11.3% reduction from 111.0K holdings) at $90.00 on 2026-06-17, netting $1,124,100.00. The stock currently trades at $88.05, representing a 10.9% pullback from its 52-week high of $98.79, though it has gained 10.2% over the past 30 days. Across his prior trades at CAVA specifically, 4 of 4 prior sells have been well-timed at the 90-day mark, indicating a pattern where the stock declined after Costanza's sales. This latest sale occurs in a stock with elevated valuation (P/E of 166.13) that is growing revenue at 22.4% annually, creating a backdrop where insider selling may signal reassessment of risk-reward at current multiples.

Participations S.A R.L. Artal (Director) sold 3,000,000 shares of CAVA at $90.30 for $270,900,000

Participations S.A R.L. Artal sold 3,000,000 shares representing -31.6% of pre-transaction holdings, reducing stakes from 9,507,990 shares to 6,507,990 shares. The sale occurred at $90.30 per share when current price stands at $88.05, near the 52-week high of $98.79 and well above the 52-week low of $43.41. Despite strong revenue growth of +22.4% year-over-year, the company trades at an elevated P/E of 166.13, which constrains near-term upside expectations. The director's substantial reduction in position size, combined with the high valuation multiple, provides context for the magnitude and timing of this divestiture.

CLO Joseph John Kadow purchases 1,000 shares of CAVA at $70.00; stock down -26.5% from 52-week high of $98.79

Joseph John Kadow, serving as CLO & Secretary, purchased 1,000 shares at $70.00 on 2026-06-03, increasing his holdings from 5,974 shares to 6,974 shares. The transaction occurs amid significant recent price weakness: the stock trades at $72.63, representing -26.5% from its 52-week high of $98.79 and -18.9% over the past 30 days. While the company maintains solid annual revenue growth of +22.4%, the elevated P/E of 137.04 reflects market skepticism despite the expansion. This buy by a senior executive at depressed levels warrants attention as context for investor evaluation of the firm's trajectory and insider perspective on valuation at current prices.

COO Douglas W. Thompson buys 2,500 shares of CAVA at $77.90; stock down 26.7% from 52-week high.

Chief Operations Officer Douglas W. Thompson purchased 2,500 shares at $77.90 on 2026-05-29, increasing his holdings by 24.1% to 12,871 shares post-transaction. The purchase occurred after CAVA declined 26.7% from its 52-week high of $98.79 and 20.4% over the prior 30 days, with the stock currently trading at $72.44 — below the transaction price. Despite the stock's recent weakness, the company maintains strong fundamentals with annual revenue growth of 22.4% and an $8.4B market cap. The timing of this open-market buy during a material drawdown warrants attention to whether it reflects management's assessment of current valuation relative to the business momentum, particularly given the elevated P/E of 136.68 which limits margin-of-safety interpretation.

CAVA CLO Joseph Kadow bought 1,000 shares at $79.00 on 2026-05-29; stock down 26.7% from 52-week high.

Joseph John Kadow, the company's Chief Legal Officer and Secretary, purchased 1,000 shares at $79.00, increasing his holdings from 4,974 to 5,974 shares (+20.1%). The transaction occurred when the stock was trading 26.7% below its 52-week high of $98.79 and down 20.4% over the prior 30 days. CAVA Group maintains strong revenue growth at +22.4% annually, though the stock carries a high P/E of 136.68. The timing of an insider purchase following significant recent price declines warrants monitoring alongside the company's valuation metrics, though a single transaction from one executive does not necessarily indicate a broader organizational view.

COO Douglas W. Thompson bought 4,000 CAVA shares at $79.45; holdings now 10,371 shares, up 62.8%.

Douglas W. Thompson, CAVA's Chief Operations Officer, purchased 4,000 shares at $79.45 on 2026-05-26, increasing his holdings from 6,371 to 10,371 shares (a 62.8% increase in position size). The transaction occurred when the stock was trading -20.8% below its 52-week high and has declined 14.1% in the 30 days since the purchase. The company demonstrates solid operational momentum with annual revenue growth of +22.4%, though the elevated P/E of 147.55 reflects market expectations for continued expansion. An insider purchase of this magnitude by a C-suite operational officer, coupled with the recent pullback from peak valuations, warrants monitoring to track whether this represents accumulation at a discounted entry point or a signal of management's conviction in the business fundamentals.

CLO Bertram Kenneth Robert sells 15,000 CAVA shares at $80.33; holds 37,958 post-sale as stock trades -21.2% from 52-week high.

Bertram Kenneth Robert, the Chief Legal Officer and Secretary, sold 15,000 shares (28.3% reduction in his CAVA position) at $80.33 on 2026-03-05 for $1,204,950.00. This is his second material reduction in the stock within four months—his prior sale on 2024-12-06 occurred at the tail end of a period that produced a 90-day loss of 45.0%, and his 2024-06-18 sale was followed by a 90d gain of 28.9%, yielding a 50.00% well-timed rate on his cross-ticker sell history. At CAVA specifically, his timing on prior sales (4 of 5 trades well-timed at 90 days) is materially stronger than his cross-ticker average. The current price of $78.59 is 21.2% below the 52-week high and the stock has rallied 47.3% over 90 days and 20.2% over 30 days, suggesting the sale occurred near recent strength. Given that the stock trades at a P/E of 128.84 against annual revenue growth of 22.4%, and the insider retained 37,958 shares, this sale warrants observation of the 90-day performance relative to his historical CAVA sell patterns.

Chief People Officer Costanza Kelly sold 31,803 shares of CAVA at $84.45; prior 3 same-ticker sales all well-timed to 90-day declines.

Costanza Kelly, Chief People Officer, sold 31,803 shares (20.4% of her pre-transaction holdings) at $84.45 on 2026-02-26 for $2,685,763.35. Her prior three sales at CAVA occurred on 2025-05-21, 2025-01-02, and 2025-01-02, with 90-day outcomes of -21.0%, -21.4%, and -21.7% respectively—all three well-timed to declines. Over her cross-ticker history (3 prior sells), she maintains a 100.00% well-timed rate at the 90-day mark, suggesting consistent ability to exit before subsequent weakness. CAVA stock is currently at $78.49, down 21.3% from its 52-week high of $99.70, and has risen 29.5% over the past 30 days but 48.8% over 90 days—tracking broadly with the magnitude of her prior post-sale declines. The stock trades at a P/E of 128.67 on 22.4% annual revenue growth, suggesting elevated valuation. Her pattern across three completed same-ticker positions warrants tracking for how this fourth sale performs against her demonstrated track record.

CEO Schulman buys 150 CAVA shares at $48.98; stock down -67.7% from 52-wk high, down -23.0% in 30 days

Schulman, as CEO and President, purchased 150 shares at $48.98 on 2025-11-12, establishing his first stake at this company. The purchase occurs amid significant recent price deterioration: CAVA is trading down -67.7% from its 52-week high of $150.88 and down -23.0% over the past 30 days. Historically, Schulman's prior 5 trades at CAVA were all sells, with a 100% well-timed rate at the 90-day mark (negative 90-day returns in all cases). His cross-ticker track record shows 15 prior sells with a 66.67% well-timed rate over 90 days. The shift from repeated selling to a buy merits observation given the stock's severe drawdown, though the small 150-share position ($7.3K) limits visibility into any larger strategic shift.

CAVA Director Shaich sold 1,367,221 shares for $204,262,817.40 on 2024-12-09, reducing holdings by 84.4%

Ronald M. Shaich, a director of CAVA GROUP, INC., executed three separate sales totaling 1,367,221 shares (1.37M shares) for $204,262,817.40 ($204.3M) at a blended average price of $149.40 on 2024-12-09. This transaction reduced his holdings from 1,620,527 shares to 253,306 shares—an 84.4% reduction in his position. Notably, the execution price of $149.40 represents a recent peak near the 52-week high of $150.88; the stock has since declined 15.4% to the current price of $127.59, falling 13.7% over the past 30 days. In the context of his prior CAVA trades, Shaich's five previous sales at this ticker (all in August and September 2024) were followed by positive 90-day returns, with a timing pattern of 0 of 5 well-timed (0% success rate at capturing declines). The massive scale and near-peak execution of this transaction—liquidating the vast majority of his director-level stake—stands in contrast to the company's strong fundamentals: 29.2% annual revenue growth and a $14.6B market cap, though the elevated P/E of 579.95 reflects current valuation pressures.